Abstract:OBJECTIVE To investigate the expression of carcinoembryonic antigen (CEA) and cytokeratin19 (CK19) mRNAs in peripheral blood of patients with lung cancer and their correlation with staging, treatment response and prognosis. METHODS CEA and CK19 mRNAs in peripheral blood were detected by Taq Man reverse transcriptase-polymerase chain reaction (RT-PCR) in 78 patients with lung cancer before and after treatment, 30 patients with benign lung diseases and 30 healthy subjects. Serum CEA and CYFRA21-1 levels were also measured by enzyme linked immunosorbent assay (ELISA) in the 78 patients with lung cancer before treatment. The patients were followed for 2 years. RESULTS The positive rates of CEA mRNA and CK19 mRNA in patients with lung cancer were 69.2% (54/78) and 62.8% (49/78), respectively, which were significantly higher than those in patients with benign lung diseases and the healthy controls (P < 0.01). The positive rate of CEA mRNA was the highest in adenocarcinoma, while the positive rate of CK19 mRNA was the highest in squamous cell carcinoma. There was no statistically significant difference among different stages (P > 0.05), The positive rates of CEA mRNA and CK19 mRNA were higher than those of serum CEA and CYFRA21-1. The positive rates of CEA mRNA and CK19 mRNA decreased significantly after surgical operation, but there was no significant change after chemotherapy. The median survival time (MST) for patients with a positive CEA mRNA before chemotherapy was shorter than those with a negative CEA mRNA (8.5 month and 11.7 month, respectively). The MST for patients with a positive CK19 mRNA before chemotherapy was shorter than those with a negative CK19 mRNA (8.9 month and 12.3 month, respectively). The rate of relapse and metastasis was higher in patients (29.4%) with a positive CEA mRNA preoperatively than those with a negative CEA mRNA (7.7%). The rate of relapse and metastasis was also higher in patients with a positive CK19 mRNA preoperatively (18.8%) as compared to those with a negative PCR result (7.1%). CONCLUSIONS CEA and CK19 mRNAs can be used as markers in the detection of tumor micrometastases in lung cancer, and in evaluating surgical response and prognosis. The results suggest that the gene markers are better than the serum ones, and therefore may be useful for the early diagnosis of lung cancer.

Detection and Clinicopathologic Significance of CK20,CK19,CEA Mrna in Peripheral Blood from Patients with Esophageal Cancer

Clinical Significance of CK20, CK19, CEA Mrnas in Peripheral Blood from Lung Cancer Patients

THE EXPRESSION AND CLINICAL SIGNIFICANCE OF CYTOKERATIN 20 mRNA IN CENTRAL VEIN BLOOD OF PATIENTS WITH GASTRIC CANCER BY RT-PCR

Co-expression of MAGEA3,hSTC1,CK20,CK19 and CEA mRNA in Peripheral Blood of Patients with Esophageal Carcinoma by Multiplex RT-PCR

Clinical significance of CEA and CK20 expression in exfoliated cells by fiberoptic bronchoscopy brushing

Significance of cytokeratine detection for micrometastatic tumor cells in peripheral blood and bone marrow in patients with esophageal cancer

Detection of Histospecific Mrna in Peripheral Blood from Patients with Gastrointestinal Carcinoma and Its Clinical Significance

Molecular Detection of Disseminated Tumor Cells in the Peripheral Blood of Patients with Gastric Cancer: Evaluation of Their Prognostic Significance

[Combined Detection of CEA Mrna and CK 19 Mrna in Peripheral Blood Cells of Patients with Lung Cancer].

Quantitative Real-Time RT-PCR Detection for CEA, CK20 and CK19 Mrna in Peripheral Blood of Colorectal Cancer Patients.

Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer

[Detection of CK19 and CEA mRNA expression for the diagnosis of peripheral blood micrometastases in patients with non-small cell lung cancer].

Detection of CEA Mrna and HNP1-3 in Peripheral Blood of Patients with Colorectal Cancer and Its Clinical Significance

Detection and quantification of circulating tumor cells in esophageal squamous cancer by real-time fluorescent quantitative reverse transcription-polymerase chain reaction

[Correlation between the mRNA levels of carcinoembryonic antigen and cytokeratin 19 in peripheral blood with staging, treatment response and prognosis in patients with lung cancer].

Detection of Micrometastasis in the Bone Marrow of Patients with Esophageal Carcinomas and Its Clinical Implications

Multipoint Quantification of Multimarker Genes in Peripheral Blood and Micrometastasis Characteristic in Peri-Operative Esophageal Cancer Patients

Clinical Significance of Preoperative and Postoperativecytokeratin 19messenger RNA Level in Peripheral Blood of Esophageal Cancer Patients

Carcinoembryonic Antigen Mrna Expression in Peripheral Blood of Patients with Carcinoem Bryonie Antigen-Producing Tumors

The Clinical Value of CEA Mrna、cea Protein of Peripheral Blood in the Prediction of Colorectal Cancer

Detection of CEA Mrna-Positive Circulating Tumor Cells in Patients with Early Breast Cancer and Its Clinical Sig-nificance